| 1 |
Sui L, Wang S, Ganguly D, El Rayes TP, Askeland C, Børretzen A, Sim D, Halvorsen OJ, Knutsvik G, Arnes J, Aziz S, Haukaas S, Foulkes WD, Bielenberg DR, Ziemys A, Mittal V, Brekken RA, Akslen LA, Watnick RS. PRSS2 remodels the tumor microenvironment via repression of Tsp1 to stimulate tumor growth and progression. Nat Commun 2022;13:7959. [PMID: 36575174 DOI: 10.1038/s41467-022-35649-9] [Reference Citation Analysis]
|
| 2 |
Lee DW, Cho CM. Predicting Severity of Acute Pancreatitis. Medicina (Kaunas) 2022;58:787. [PMID: 35744050 DOI: 10.3390/medicina58060787] [Reference Citation Analysis]
|
| 3 |
Yewale R, Vinish D, Jayaraman K, Chand N, Papalkar P, Ramakrishna B. Urine trypsinogen-2 as a noninvasive screening test for predicting post-ERCP pancreatitis (PEP). Gastroenterol Hepatol Endosc Pract 2022;2:41. [DOI: 10.4103/ghep.ghep_2_22] [Reference Citation Analysis]
|
| 4 |
Rainio M, Lindström O, Udd M, Puolakkainen P, Stenman UH, Kylänpää L. Repeated Negative Urine Trypsinogen-2 Dipstick Test Rules Out Diagnosis of Post-ERCP Pancreatitis. J Clin Gastroenterol 2021;55:361-6. [PMID: 32925303 DOI: 10.1097/MCG.0000000000001429] [Reference Citation Analysis]
|
| 5 |
Sui L, Wang S, Ganguly D, El Rayes T, Askeland C, Børretzen A, Sim D, Halvorsen OJ, Knutsvik G, Aziz S, Haukaas S, Foulkes WD, Bielenberg DR, Ziemys A, Mittal V, Brekken RA, Akslen LA, Watnick RS. PRSS2 stimulates tumor growth by remodeling the TME via repression of Tsp1.. [DOI: 10.1101/2021.03.23.436667] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 6 |
Divyapicigil M, Pirincci Gokturk SS, Ergenoglu B, Yucel F, Akcael EA. Development of mutant human immunoreactive trypsinogen 1 (IRT1) and mutant human immunoreactive trypsinogen 2 (IRT2) for use in immunoassays. Protein Expr Purif 2020;169:105572. [PMID: 31972264 DOI: 10.1016/j.pep.2020.105572] [Reference Citation Analysis]
|
| 7 |
Yasuda H, Kataoka K, Takeyama Y, Takeda K, Ito T, Mayumi T, Isaji S, Mine T, Kitagawa M, Kiriyama S, Sakagami J, Masamune A, Inui K, Hirano K, Akashi R, Yokoe M, Sogame Y, Okazaki K, Morioka C, Kihara Y, Kawa S, Tanaka M, Andoh A, Kimura W, Nishimori I, Furuse J, Yokota I, Shimosegawa T. Usefulness of urinary trypsinogen-2 and trypsinogen activation peptide in acute pancreatitis: A multicenter study in Japan. World J Gastroenterol 2019; 25(1): 107-117 [PMID: 30643362 DOI: 10.3748/wjg.v25.i1.107] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 8 |
Morin TJ, McKenna WL, Shropshire TD, Wride DA, Deschamps JD, Liu X, Stamm R, Wang H, Dunbar WB. A handheld platform for target protein detection and quantification using disposable nanopore strips. Sci Rep 2018;8:14834. [PMID: 30287843 DOI: 10.1038/s41598-018-33086-7] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 9 |
Rompianesi G, Hann A, Komolafe O, Pereira SP, Davidson BR, Gurusamy KS. Serum amylase and lipase and urinary trypsinogen and amylase for diagnosis of acute pancreatitis. Cochrane Database Syst Rev. 2017;4:CD012010. [PMID: 28431198 DOI: 10.1002/14651858.cd012010.pub2] [Cited by in Crossref: 24] [Cited by in F6Publishing: 38] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 10 |
Wang K, Cui D. The Application of Immunochromatographic Analysis in Early Detection of Gastric Cancer. Translational Medicine Research 2017. [DOI: 10.1007/978-94-024-0951-2_8] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 11 |
Gurusamy KS, Davidson BR. Serum amylase and lipase and urinary trypsinogen and amylase for diagnosis of acute pancreatitis and serum C-reactive protein, procalcitonin and lactate dehydrogenase for the diagnosis of pancreatic necrosis. Cochrane Database of Systematic Reviews 2015. [DOI: 10.1002/14651858.cd012010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 12 |
Meher S, Mishra TS, Sasmal PK, Rath S, Sharma R, Rout B, Sahu MK. Role of Biomarkers in Diagnosis and Prognostic Evaluation of Acute Pancreatitis. J Biomark 2015;2015:519534. [PMID: 26345247 DOI: 10.1155/2015/519534] [Cited by in Crossref: 39] [Cited by in F6Publishing: 47] [Article Influence: 4.9] [Reference Citation Analysis]
|
| 13 |
Koutroumpakis EI, Papachristou GI. Post–endoscopic retrograde cholangiopancreatography pancreatitis: Overview and pathophysiology. Techniques in Gastrointestinal Endoscopy 2014;16:150-155. [DOI: 10.1016/j.tgie.2014.09.004] [Reference Citation Analysis]
|
| 14 |
Feng N, Dai J, Lu H, Li XB, Gao YJ, Ge ZZ. Hyperamylasemia is associated with increased intestinal permeability in patients undergoing diagnostic oral double-balloon enteroscopy. World J Gastroenterol 2014; 20(2): 539-545 [PMID: 24574723 DOI: 10.3748/wjg.v20.i2.539] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 15 |
Jin T, Huang W, Jiang K, Xiong JJ, Xue P, Javed MA, Yang XN, Xia Q. Urinary trypsinogen-2 for diagnosing acute pancreatitis: a meta-analysis. Hepatobiliary Pancreat Dis Int 2013;12:355-62. [PMID: 23924492 DOI: 10.1016/s1499-3872(13)60056-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 16 |
El-garem H, Hamdy E, Hamdy S, El-sayed M, Elsharkawy A, Saleh AM. Use of the urinary trypsinogen-2 dipstick test in early diagnosis of pancreatitis after endoscopic retrograde cholangiopancreatography (ERCP). OJGas 2013;03:289-294. [DOI: 10.4236/ojgas.2013.36049] [Reference Citation Analysis]
|
| 17 |
Mayumi T, Inui K, Maetani I, Yokoe M, Sakamoto T, Yoshida M, Ko S, Hirata K, Takada T; Urinary Trypsinogen-2 Dipstick for Acute Pancreatitis Study Group of Japanese Society of Abdominal Emergency Medicine (UtrAP Study Group). Validity of the urinary trypsinogen-2 test in the diagnosis of acute pancreatitis. Pancreas 2012;41:869-75. [PMID: 22481290 DOI: 10.1097/MPA.0b013e3182480ab7] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 18 |
Uemura K, Murakami Y, Sudo T, Hashimoto Y, Nakashima A, Yamaoka E, Sueda T. Elevation of urine trypsinogen 2 is an independent risk factor for pancreatic fistula after pancreaticoduodenectomy. Pancreas 2012;41:876-81. [PMID: 22357509 DOI: 10.1097/MPA.0b013e31823d0b82] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 19 |
Tseng CW, Chen CC, Lin SZ, Chang FY, Lin HC, Lee SD. Rapid urinary trypsinogen-2 test strip in the diagnosis of pancreatitis after endoscopic retrograde cholangiopancreatography. Pancreas 2011;40:1211-4. [PMID: 21946810 DOI: 10.1097/MPA.0b013e31821fcdcf] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 20 |
Kobayashi K, Sasaki T, Serikawa M, Inoue M, Itsuki H, Chayama K. Assessment of trypsinogen-2 levels as an early diagnostic for post-endoscopic retrograde cholangiopancreatography pancreatitis. Pancreas 2011;40:1206-10. [PMID: 21792081 DOI: 10.1097/MPA.0b013e318223d362] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 21 |
Andersen AM, Novovic S, Ersbøll AK, Jorgensen LN, Hansen MB. Urinary trypsinogen-2 dipstick in acute pancreatitis. Pancreas 2010;39:26-30. [PMID: 19752771 DOI: 10.1097/MPA.0b013e3181ba314f] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 22 |
Jordanov P, Grigorov G, Todorova S, Angov R, Hristov V, Vukov M. Application of an Express Urinary Trypsinogen-2 Test for the Diagnosis of Acute Pancreatitis. Point of Care: The Journal of Near-Patient Testing & Technology 2009;8:21-24. [DOI: 10.1097/poc.0b013e318197b789] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 23 |
Kamer E, Unalp HR, Derici H, Tansug T, Onal MA. Early diagnosis and prediction of severity in acute pancreatitis using the urine trypsinogen-2 dipstick test: a prospective study. World J Gastroenterol. 2007;13:6208-6212. [PMID: 18069761 DOI: 10.3748/wjg.13.6208] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 24 |
Kamer E, Unalp HR, Derici H, Tansug T, Onal MA. Early diagnosis and prediction of severity in acute pancreatitis using the urine trypsinogen-2 dipstick test: A prospective study. World J Gastroenterol 2007; 13(46): 6208-6212 [PMID: 18069761 DOI: 10.3748/wjg.v13.i46.6208] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 9] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 25 |
Sankaralingam S, Wesen C, Barawi M, Galera R, Lloyd L. Use of the urinary trypsinogen-2 dip stick test in early diagnosis of pancreatitis after endoscopic retrograde cholangiopancreatography. Surg Endosc. 2007;21:1312-1315. [PMID: 17332967 DOI: 10.1007/s00464-006-9099-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 26 |
Gullo L. Acute pancreatitis: diagnostic gold standard — new perspectives? Pancreatitis: Advances in Pathobiology, Diagnosis and Treatment. [DOI: 10.1007/1-4020-2915-2_4] [Reference Citation Analysis]
|
| 27 |
Sáez J, Martínez J, Trigo C, Sánchez-Payá J, Compañy L, Laveda R, Griñó P, García C, Pérez-Mateo M. Clinical value of rapid urine trypsinogen-2 test strip, urinary trypsinogen activation peptide, and serum and urinary activation peptide of carboxypeptidase B in acute pancreatitis. World J Gastroenterol 2005;11:7261-5. [PMID: 16437625 DOI: 10.3748/wjg.v11.i46.7261] [Cited by in CrossRef: 28] [Cited by in F6Publishing: 31] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 28 |
Kitagawa M. Current concept for diagnosis of acute pancreatitis. Journal of the Japan Pancreas Society 2006;21:491-494. [DOI: 10.2958/suizo.21.491] [Reference Citation Analysis]
|
| 29 |
Hernández CA, Nicolás JC, Fernández J, Pizarro P. Determination of plasma trypsin-like activity in healthy subjects, patients with mild to moderate alcoholic chronic pancreatitis, and patients with nonjaundice pancreatic cancer. Dig Dis Sci 2005;50:2165-9. [PMID: 16240234 DOI: 10.1007/s10620-005-3026-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 30 |
Chen YT, Chen CC, Wang SS, Chang FY, Lee SD. Rapid urinary trypsinogen-2 test strip in the diagnosis of acute pancreatitis. Pancreas 2005;30:243-7. [PMID: 15782102 DOI: 10.1097/01.mpa.0000153618.48137.ef] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 31 |
Puolakkainen PA. Selecting Severe Cases of Acute Pancreatitis for Trials and for Treatment: Enzymes and Activation Peptides. Pancreatic Disease 2004. [DOI: 10.1007/978-1-85233-904-3_29] [Reference Citation Analysis]
|
| 32 |
Werner J, Hartwig W, Uhl W, Müller C, Büchler MW. Useful markers for predicting severity and monitoring progression of acute pancreatitis. Pancreatology 2003;3:115-27. [PMID: 12748420 DOI: 10.1159/000070079] [Cited by in Crossref: 76] [Cited by in F6Publishing: 80] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 33 |
Müller CA, Appelros S, Uhl W, Büchler MW, Borgström A. A study on the activation peptide released from procarboxypeptidase B (CAPAP) and anionic trypsinogen in patients with acute abdominal disorders of non-pancreatic origin. Pancreatology 2003;3:149-55. [PMID: 12748424 DOI: 10.1159/000070084] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 34 |
Waritani T, Okuno Y, Ashida Y, Hisasue M, Tsuchiya R, Kobayashi K, Yamada T. Development of a canine trypsin-like immunoreactivity assay system using monoclonal antibodies. Vet Immunol Immunopathol 2002;87:41-9. [PMID: 12052341 DOI: 10.1016/s0165-2427(02)00120-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 35 |
Müller CA, Appelros S, Uhl W, Büchler MW, Borgström A. Serum levels of procarboxypeptidase B and its activation peptide in patients with acute pancreatitis and non-pancreatic diseases. Gut 2002;51:229-35. [PMID: 12117885 DOI: 10.1136/gut.51.2.229] [Cited by in Crossref: 41] [Cited by in F6Publishing: 44] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 36 |
Kylänpää-Bäck ML, Repo H, Kemppainen E. New laboratory tests in acute pancreatitis. Addict Biol 2002;7:181-90. [PMID: 12006214 DOI: 10.1080/13556210220120415] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 37 |
Toouli J, Brooke-Smith M, Bassi C, Carr-Locke D, Telford J, Freeny P, Imrie C, Tandon R; Working Party of the Program Commitee of the Bangkok World Congress of Gastroenterology 2002. Guidelines for the management of acute pancreatitis. J Gastroenterol Hepatol 2002;17 Suppl:S15-39. [PMID: 12000591 DOI: 10.1046/j.1440-1746.17.s1.2.x] [Cited by in Crossref: 254] [Cited by in F6Publishing: 295] [Article Influence: 12.1] [Reference Citation Analysis]
|
| 38 |
Chwistek M, Roberts I, Amoateng-Adjepong Y. Gallstone pancreatitis: a community teaching hospital experience. J Clin Gastroenterol 2001;33:41-4. [PMID: 11418789 DOI: 10.1097/00004836-200107000-00010] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 39 |
Pontezière C, Bugugnani M. Évaluation clinique du trypsinogène-2 urinaire par le test rapide Actim pancreatitis™ au cours d'atteintes pancréatiques. Immuno-analyse & Biologie Spécialisée 2001;16:246-250. [DOI: 10.1016/s0923-2532(01)80018-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
|
| 40 |
Pezzilli R, Morselli-Labate AM, d'Alessandro A, Barakat B. Time-course and clinical value of the urine trypsinogen-2 dipstick test in acute pancreatitis. Eur J Gastroenterol Hepatol 2001;13:269-74. [PMID: 11293447 DOI: 10.1097/00042737-200103000-00009] [Cited by in Crossref: 14] [Cited by in F6Publishing: 18] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 41 |
Hedström J, Kemppainen E, Andersén J, Jokela H, Puolakkainen P, Stenman UH. A comparison of serum trypsinogen-2 and trypsin-2-alpha1-antitrypsin complex with lipase and amylase in the diagnosis and assessment of severity in the early phase of acute pancreatitis. Am J Gastroenterol 2001;96:424-30. [PMID: 11232685 DOI: 10.1111/j.1572-0241.2001.03457.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 14] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 42 |
Pressac M, Guilhaume C. Marqueurs d'une atteinte pancréatique. Immuno-analyse & Biologie Spécialisée 1999;14:227-231. [DOI: 10.1016/s0923-2532(99)80056-8] [Reference Citation Analysis]
|
| 43 |
Petersson U, Appelros S, Borgström A. Different patterns in immunoreactive anionic and cationic trypsinogen in urine and serum in human acute pancreatitis. Int J Pancreatol 1999;25:165-70. [PMID: 10453418 DOI: 10.1007/BF02925965] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 44 |
Rinderknecht H. Letter to the editor. Int J Pancreatol 1996;20:141-141. [DOI: 10.1007/bf02825514] [Cited by in Crossref: 1] [Article Influence: 0.0] [Reference Citation Analysis]
|
